{"id":"W3023558472","doi":"10.1093/annonc/mdw364.65","title":"Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: final analysis of the randomised, two-cohort PrefHer study","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Trastuzumab; Population; Cohort; Adverse effect; Breast cancer; Internal medicine; Confidence interval; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006823477,0.002037936,0.004196879,0.000514042,0.000405292,0.001537069,0.001511323,0.002443862,0.003521193],"category_scores_gemma":[0.007090854,0.001208474,0.004450426,0.0006091749,0.002436234,0.00207237,0.0008353514,0.003561744,0.0007865559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001356669,"about_ca_system_score_gemma":0.001474118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001138101,"about_ca_topic_score_gemma":0.001272809,"domain_scores_codex":[0.9946062,0.003627412,0.0002686489,0.0006041454,0.0003546668,0.0005389313],"domain_scores_gemma":[0.994217,0.002684508,0.0009519369,0.001105825,0.000270317,0.0007703431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9892292,0.002168348,0.001228191,0.0000905314,0.0008878049,0.0000173271,0.00003801718,0.0002470299,0.001131068,0.00003775026,0.00009576769,0.004829087],"study_design_scores_gemma":[0.8110058,0.1686554,0.01486686,0.00003127904,0.002899205,0.00005355836,0.00005299237,0.0007332435,0.0009833873,0.0002624107,0.000403801,0.00005197375],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967096,0.001345771,0.0003803792,0.0001366008,0.0001308187,0.0003408081,0.0004120723,0.000028283,0.0005156943],"genre_scores_gemma":[0.9966834,0.0005944973,0.0004032904,0.0001745721,0.0002108534,0.0003004604,0.0007091338,0.00001994815,0.0009037563],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006823477,"threshold_uncertainty_score":0.03608644,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05644000073511748,"score_gpt":0.4070871109882137,"score_spread":0.3506471102530961,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}